IBD (inflammatory bowel disease)-related tissue damage occurs in areas which are massively infiltrated with monocytes/macrophages. These cells respond to inflammatory stimuli with enhanced production of cytokines/chemokines. In the present study, we analysed the expression and role of IL (interleukin)-34, a regulator of monocyte/macrophage differentiation, survival and function, in IBD. A significant increase in IL-34 mRNA and protein expression was seen in inflamed mucosa of patients with CD (Crohn's disease) and patients with UC (ulcerative colitis) compared with the uninvolved areas of the same patients and normal controls. IL-34 was up-regulated in LPMCs (lamina propria mononuclear cells) isolated from normal colon by TNF-α (tumour necrosis factor α) and TLR (Toll-like receptor) ligands and was down-regulated in intestinal biopsies and LPMCs of IBD patients upon treatment with infliximab. Treatment of normal LPMCs with IL-34 increased TNF-α expression in an ERK1/2 (extracellular-signal-regulated kinase 1/2)-dependent fashion and neutralization of IL-34 in IBD mucosal explants reduced TNF-α and IL-6 synthesis. In conclusion, our results indicate that IL-34 is up-regulated in IBD and suggest a role for this cytokine in sustaining the inflammatory responses in this disease.

Franze, E., Monteleone, I., Cupi, M.L., Mancia, P., Caprioli, F., Marafini, I., et al. (2015). Interleukin-34 sustains inflammatory pathways in the gut. CLINICAL SCIENCE, 129(3), 271-280 [10.1042/CS20150132].

Interleukin-34 sustains inflammatory pathways in the gut

Franze E.;Monteleone I.;Cupi M. L.;Marafini I.;Ortenzi A.;Sica G.;Sileri P.;Pallone F.;Monteleone G.
2015

Abstract

IBD (inflammatory bowel disease)-related tissue damage occurs in areas which are massively infiltrated with monocytes/macrophages. These cells respond to inflammatory stimuli with enhanced production of cytokines/chemokines. In the present study, we analysed the expression and role of IL (interleukin)-34, a regulator of monocyte/macrophage differentiation, survival and function, in IBD. A significant increase in IL-34 mRNA and protein expression was seen in inflamed mucosa of patients with CD (Crohn's disease) and patients with UC (ulcerative colitis) compared with the uninvolved areas of the same patients and normal controls. IL-34 was up-regulated in LPMCs (lamina propria mononuclear cells) isolated from normal colon by TNF-α (tumour necrosis factor α) and TLR (Toll-like receptor) ligands and was down-regulated in intestinal biopsies and LPMCs of IBD patients upon treatment with infliximab. Treatment of normal LPMCs with IL-34 increased TNF-α expression in an ERK1/2 (extracellular-signal-regulated kinase 1/2)-dependent fashion and neutralization of IL-34 in IBD mucosal explants reduced TNF-α and IL-6 synthesis. In conclusion, our results indicate that IL-34 is up-regulated in IBD and suggest a role for this cytokine in sustaining the inflammatory responses in this disease.
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/18 - Chirurgia Generale
English
Con Impact Factor ISI
Colitis, Ulcerative; Crohn Disease; Enteroendocrine Cells; Humans; Inflammation; Interleukins; MAP Kinase Signaling System; Macrophages; Tumor Necrosis Factor-alpha
Franze, E., Monteleone, I., Cupi, M.L., Mancia, P., Caprioli, F., Marafini, I., et al. (2015). Interleukin-34 sustains inflammatory pathways in the gut. CLINICAL SCIENCE, 129(3), 271-280 [10.1042/CS20150132].
Franze, E; Monteleone, I; Cupi, Ml; Mancia, P; Caprioli, F; Marafini, I; Colantoni, A; Ortenzi, A; Laudisi, F; Sica, G; Sileri, P; Pallone, F; Monteleone, G
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2108/197038
Citazioni
  • ???jsp.display-item.citation.pmc??? 23
  • Scopus 49
  • ???jsp.display-item.citation.isi??? 45
social impact